Ethicon widens distribution of biopsy product
The Lorad division of Hologic and Ethicon Endo-Surgery have struck a nonexclusive distribution agreement for Ethicon’s minimally invasive breast biopsy system, the Mammotome ST. Under terms of the agreement, which pertains only to the U.S., Hologic
The Lorad division of Hologic and Ethicon Endo-Surgery have struck a nonexclusive distribution agreement for Ethicon’s minimally invasive breast biopsy system, the Mammotome ST. Under terms of the agreement, which pertains only to the U.S., Hologic may offer the Mammotome ST for purchase with Lorad’s MultiCare and StereoLoc II stereotactic breast biopsy systems. The Mammotome ST is complementary to and compatible with Lorad’s two breast biopsy systems, which use digital imaging to pinpoint the location of suspicious lesions. The Mammotome ST can be used to obtain multiple tissue samples through a single, relatively small incision in the skin, using only local anesthesia. Open surgical biopsy removes a large section of tissue through a 1 to 3-inch incision, often under general anesthesia.
New MRI Research Explores Links Between Waist-to-Hip Ratio and Memory in Aging
March 13th 2025Researchers found that a higher waist-to-hip ratio in midlife was associated with higher mean diffusivity in 26 percent of total white matter tracts in the cingulum as well as the superior and inferior longitudinal fasciculus.
Can Ultrasound-Based Radiomics Enhance Differentiation of HER2 Breast Cancer?
March 11th 2025Multicenter research revealed that a combined model of clinical factors and ultrasound-based radiomics exhibited greater than a 23 percent higher per patient-level accuracy rate for identifying HER2 breast cancer than a clinical model.
